Quinoline, 3-chloro-7-(trifluoromethyl)-(104612-21-7)
- Name: Quinoline, 3-chloro-7-(trifluoromethyl)-
- Synonyms:
- Molecular Formula:C10H5ClF3N
- Molecular Weight:
- CAS Registry Number:104612-21-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.104612-21-7 Quinoline, 3-chloro-7-(trifluoromethyl)-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.104612-21-7 3-Chloro-7-(trifluoromethyl)quinoline
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 104607-74-1/2-Benzoxazolamine, N-4-piperidinyl-
- 104607-75-2/2-Benzoxazolamine, N-[1-[2-[(4-fluorophenyl)amino]ethyl]-4-piperidinyl]-
- 104607-76-3/2-Benzoxazolamine, N-[1-[2-[(4-fluorophenyl)amino]ethyl]-4-piperidinyl]-N-methyl-
- 104607-77-4/2-Benzoxazolamine, N-[1-[2-(4-pyridinyl)ethyl]-4-piperidinyl]-
- 104607-78-5/2-Benzoxazolamine, N-[1-[2-(2-pyridinyl)ethyl]-4-piperidinyl]-
- 104607-79-6/2-Benzoxazolamine, N-methyl-N-[1-[2-(2-pyridinyl)ethyl]-4-piperidinyl]-
- 104607-83-2/2-Benzothiazolamine, N-[1-[4-(4-fluorophenoxy)cyclohexyl]-4-piperidinyl]-N-methyl-, trans-
- 104607-89-8/4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-methoxy-3-phenyl-
- 104608-53-9/Glycine, N-(1-methylethyl)-N-(phosphonomethyl)-
- 104610-98-2/Pyrido[3,2-f]-1,4-oxazepin-5(2H)-one, 2-[2-(dimethylamino)-1-methylethyl]-3,4-dihydro-4-methyl-
- 104610-99-3/Pyrido[3,2-f]-1,4-oxazepin-5(2H)-one, 2-[2-(dimethylamino)-1-methylethyl]-3,4-dihydro-4-methyl-, ethanedioate (1:1)
- 104611-08-7/Pyrido[3,2-f]-1,4-oxazepine-5(2H)-thione, 2-[2-(dimethylamino)-1-methylethyl]-3,4-dihydro-4-methyl-
- 104611-09-8/Pyrido[3,2-f]-1,4-oxazepine-5(2H)-thione, 2-[2-(dimethylamino)-1-methylethyl]-3,4-dihydro-4-methyl-, ethanedioate (1:1)
- 104611-10-1/Pyrido[3,2-f]-1,4-oxazepin-5(2H)-one, 2-[2-(dimethylamino)propyl]-3,4-dihydro-4-methyl-, monohydrochloride
- 104611-11-2/Pyrido[3,2-f]-1,4-oxazepin-5(2H)-one, 2-[2-(dimethylamino)propyl]-3,4-dihydro-4-methyl-
- 104611-12-3/Pyrido[3,2-f]-1,4-oxazepine-5(2H)-thione, 3,4-dihydro-4-methyl-2-[2-(2-methyl-1-pyrrolidinyl)ethyl]-
- 104611-13-4/Pyrido[3,2-f]-1,4-oxazepine-5(2H)-thione, 3,4-dihydro-4-methyl-2-[2-(2-methyl-1-pyrrolidinyl)ethyl]-, (E)-2-butenedioate (1:1)
- 10461-11-7/Phenol, 4-(2-methylpropyl)-2,6-dinitro-
- 104611-20-3/5H-1,4-Benzodiazepin-5-one, 4-ethyl-1,2,3,4-tetrahydro-2-[2-(4-hydroxy-4-phenyl-1-piperidinyl)ethyl]-1 -methyl-
- 104612-21-7/Quinoline, 3-chloro-7-(trifluoromethyl)-
- 104612-22-8/3-Quinolinecarboxylic acid, 4-chloro-7-(trifluoromethyl)-, sodium salt
- 104612-23-9/7-Isoquinolinecarboxamide, 6-hydroxy-
- 104612-24-0/7-Isoquinolinecarboxylic acid, 6-hydroxy-, methyl ester
- 104612-25-1/6-Isoquinolinecarboxamide, 7-hydroxy-
- 104612-26-2/5-Isoquinolinecarboxylic acid, 7-hydroxy-, methyl ester
- 104612-27-3/7-Quinolinecarboxylic acid, 8-hydroxy-2-methyl-, methyl ester
- 104612-28-4/7-Quinolinecarboxamide, 8-hydroxy-2-methyl-
- 104612-29-5/5-Quinolinecarboxylic acid, 6-hydroxy-, methyl ester
- 104612-31-9/7-Quinolinecarboxamide, 8-hydroxy-
- 104612-84-2/3-Pyridinecarboxylic acid, 2-[(1,4-dimethyl-3-pyrrolidinyl)oxy]-, sodium salt